InvestorsHub Logo
Followers 118
Posts 11972
Boards Moderated 0
Alias Born 12/18/2003

Re: None

Friday, 04/05/2024 11:35:23 AM

Friday, April 05, 2024 11:35:23 AM

Post# of 233151
For people who do not understand results of our critical study ,
Possibly when this study will be peer review , in some near future and published , the 82% mortality benefit ABOVE any other drug , when leronlimab is in the system ,

It will be easer for some to understand .

All imo

GLTA longs
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News